相关实验视频
Updated: Jun 4, 2025
16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
24.8K
重症患者的复苏:探索各种低血压休克病例的有效液体复苏方法-系统性审查和元分析
Eman E Shaban1, Mohamed Elgassim2, Ahmed Shaban2
1Department of Cardiology, Hamad Medical Corporation, Doha, Qatar.
Bulletin of emergency and trauma
|December 19, 2024
概括
这项研究发现,合物,包括基乙基粉,凝和专,与水晶合物相比,在患有低血压休克的重症患者中没有改善生存率. 高血压盐水加德克斯也没有显示死亡率的好处.
科学领域:
- 关键护理医学 关键护理医学
- 紧急医疗 紧急医疗
- 液体复苏 复苏 液体复苏 复苏
背景情况:
- 低血压性休克需要迅速的液体复苏.
- 复苏液的选择会影响患者的治疗结果.
- 在低血压休克中比较各种类型的流体的证据至关重要.
研究的目的:
- 为了研究不同复苏液在患有低血压休克的重症患者的疗效.
- 为了比较合体与水晶合体的死亡率益处.
- 评估高血压溶液对患者存活率的影响.
主要方法:
- 在PubMed,Web of Science,ScienceDirect,Cochrane图书馆和谷歌学者 (1990-2023) 的综合文献搜索.
- 包括以英语出版的随机对照试验.
- 使用Cochrane的偏差风险工具进行方法质量评估,并使用Review Manager软件进行统计分析.
主要成果:
- 分析了16项研究,涉及各种复苏液.
- 基乙烯粉 (HES),凝和专辑蛋白没有显示出相对于晶体质的显著死亡益处.
- 与标准晶状物相比,高血压盐水加德克斯 (HSD) 和高血压盐水没有显示出死亡率的好处.
结论:
- 结合物,单独或与高性结晶物 (HSD) 结合,在成人低血压休克中,与结晶物相比,没有死亡率优势.
- 目前的证据不支持这些合体的常规使用,以改善这种患者群体的存活率.
- 可能需要进一步的研究来确定可能受益于替代流体策略的特定患者子组.
相关概念视频
01:24Blood Pressure Imbalances and Circulatory Shock
749
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
749
01:29Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
01:22Methods of reducing fever
642
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
642
01:22Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339